Department of Non-communicable Diseases, World Health Organization, Geneva, Switzerland.
Resolve to Save Lives, New York, NY, United States.
Front Public Health. 2023 Jul 24;11:1146441. doi: 10.3389/fpubh.2023.1146441. eCollection 2023.
Cardiovascular diseases (CVD), principally ischemic heart disease (IHD) and stroke, are the leading causes of death (18. 6 million deaths annually) and disability (393 million disability-adjusted life-years lost annually), worldwide. High blood pressure is the most important preventable risk factor for CVD and deaths, worldwide (10.8 million deaths annually). In 2016, the World Health Organization (WHO) and the United States Centers for Disease Control (CDC) launched the Global Hearts initiative to support governments in their quest to prevent and control CVD. HEARTS is the core technical package of the initiative and takes a public health approach to treating hypertension and other CVD risk factors at the primary health care level. The HEARTS Partner Forum, led by WHO, brings together the following 11 partner organizations: American Heart Association (AHA), Center for Chronic Disease Control (CCDC), International Society of Hypertension (ISH), International Society of Nephrology (ISN), Pan American Health Organization (PAHO), Resolve to Save Lives (RTSL), US CDC, World Hypertension League (WHL), World Heart Federation (WHF) and World Stroke Organization (WSO). The partners support countries in their implementation of the HEARTS technical package in various ways, including providing technical expertise, catalytic funding, capacity building and evidence generation and dissemination. HEARTS has demonstrated the feasibility and acceptability of a public health approach, with more than seven million people already on treatment for hypertension using a simple, algorithmic HEARTS approach. Additionally, HEARTS has demonstrated the feasibility of using hypertension as a pathfinder to universal health coverage and should be a key intervention of all basic benefit packages. The partner forum continues to find ways to expand support and reinvigorate enthusiasm and attention on preventing CVD. Proposed future HEARTS Partner Forum activities are related to more concrete information sharing between partners and among countries, expanded areas of partner synergy, support for implementation, capacity building, and advocacy with country ministries of health, professional societies, academy and civil societies organizations. Advancing toward the shared goals of the HEARTS partners will require a more formal, structured approach to the forum and include goals, targets and published reports. In this way, the HEARTS Partner Forum will mirror successful global partnerships on communicable diseases and assist countries in reducing CVD mortality and achieving global sustainable development goals (SDGs).
心血管疾病（CVD），主要是缺血性心脏病（IHD）和中风，是全世界死亡（每年 1860 万人死亡）和残疾（每年 3.93 亿残疾调整生命年损失）的主要原因。高血压是全世界可预防的 CVD 和死亡的最重要危险因素（每年 1080 万人死亡）。2016 年，世界卫生组织（WHO）和美国疾病控制与预防中心（CDC）发起了全球心脏倡议，以支持各国努力预防和控制 CVD。HEARTS 是该倡议的核心技术包，采用公共卫生方法在初级卫生保健层面治疗高血压和其他 CVD 危险因素。由世界卫生组织牵头的 HEARTS 合作伙伴论坛汇集了以下 11 个合作伙伴组织：美国心脏协会（AHA）、慢性病控制中心（CCDC）、国际高血压学会（ISH）、国际肾脏病学会（ISN）、泛美卫生组织（PAHO）、Resolve to Save Lives（RTSL）、美国疾病控制与预防中心（CDC）、世界高血压联盟（WHL）、世界心脏联合会（WHF）和世界中风组织（WSO）。合作伙伴以各种方式支持各国实施 HEARTS 技术包，包括提供技术专长、催化资金、能力建设以及证据生成和传播。HEARTS 已经证明了公共卫生方法的可行性和可接受性，已有超过 700 万人采用简单的 HEARTS 算法方法接受高血压治疗。此外，HEARTS 还证明了将高血压作为全民健康覆盖的切入点的可行性，并且应该成为所有基本福利包的关键干预措施。合作伙伴论坛继续寻找扩大支持和重新激发预防 CVD 热情和关注的方法。未来提出的 HEARTS 合作伙伴论坛活动涉及合作伙伴之间以及国家之间更具体的信息共享、扩大合作伙伴协同作用领域、对实施的支持、能力建设以及与各国卫生部、专业协会、学会和民间社会组织的宣传。朝着 HEARTS 合作伙伴的共同目标迈进，将需要对论坛采取更正式、更结构化的方法，包括目标、指标和发布报告。通过这种方式，HEARTS 合作伙伴论坛将反映出在传染病方面成功的全球伙伴关系，并帮助各国降低 CVD 死亡率，实现全球可持续发展目标（SDG）。
